Synthesis, characterization and antimicrobial activity of novel Schiff base tethered boronate esters of 1,2-O-isopropylidene-α-d-xylofuranose.

[1]  B. Sumerlin,et al.  Synthesis and Applications of Boronic Acid-Containing Polymers: From Materials to Medicine. , 2016, Chemical reviews.

[2]  E. Aubert,et al.  Synthesis, characterization, crystal structure and DFT study of two new polymorphs of a Schiff base (E)-2-((2,6-dichlorobenzylidene)amino)benzonitrile , 2016 .

[3]  Shujun Li,et al.  Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids. , 2016, Bioorganic & medicinal chemistry letters.

[4]  F. Şahin,et al.  The synthesis of boronic-imine structured compounds and identification of their anticancer, antimicrobial and antioxidant activities☆ , 2015, Journal of pharmaceutical analysis.

[5]  P. Yogeeswari,et al.  Sugar-boronate ester scaffold tethered pyridyl-imine palladium(II) complexes: synthesis and their in vitro anticancer evaluation. , 2015, Dalton transactions.

[6]  B. Elewski,et al.  Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies. , 2015, Journal of the American Academy of Dermatology.

[7]  Kelly A McCarthy,et al.  Targeting Bacteria via Iminoboronate Chemistry of Amine-Presenting Lipids , 2015, Nature Communications.

[8]  D. Gowda,et al.  Schiff's bases of quinazolinone derivatives: Synthesis and SAR studies of a novel series of potential anti-inflammatory and antioxidants. , 2015, Bioorganic & Medicinal Chemistry Letters.

[9]  C. Ganesh Kumar,et al.  Synthesis, antimicrobial and anti-biofilm activities of novel Schiff base analogues derived from methyl-12-aminooctadec-9-enoate. , 2014, Bioorganic & medicinal chemistry letters.

[10]  Chaoliang He,et al.  Boronic acid shell-crosslinked dextran-b-PLA micelles for acid-responsive drug delivery. , 2014, Macromolecular bioscience.

[11]  Changsheng Shi,et al.  Fabrication of boronic acid-functionalized nanoparticles via boronic acid–diol complexation for drug delivery , 2014 .

[12]  Y. Miyahara,et al.  New directions in the design of phenylboronate-functionalized polymers for diagnostic and therapeutic applications , 2014 .

[13]  He-Fang Wang,et al.  Aminophenylboronic-acid-conjugated polyacrylic acid-Mn-doped ZnS quantum dot for highly sensitive discrimination of glycoproteins. , 2014, Analytical chemistry.

[14]  J. Trujillo-Ferrara,et al.  Boron-containing compounds: chemico-biological properties and expanding medicinal potential in prevention, diagnosis and therapy , 2014, Expert opinion on therapeutic patents.

[15]  V. Barba,et al.  Boron Macrocycles Based on Multicomponent Assemblies using (3-Aminophenyl)boronic Acid and Pentaerythritol as Common Reagents; Molecular Receptors toward Lewis Bases , 2014 .

[16]  C. A. Gray,et al.  Heterocyclic Aminoboron Compounds as Antituberculosis Agents , 2014 .

[17]  Chi Wu,et al.  One stone kills three birds: novel boron-containing vesicles for potential BNCT, controlled drug release, and diagnostic imaging. , 2014, Molecular pharmaceutics.

[18]  Rajiv Trivedi,et al.  Carbohydrate‐Based Ferrocenyl Boronate Esters: Synthesis, Characterization, Crystal Structures, and Antibacterial Activity , 2013 .

[19]  Y. Miyahara,et al.  Phenylboronic acid-installed polymeric micelles for targeting sialylated epitopes in solid tumors. , 2013, Journal of the American Chemical Society.

[20]  Sha Long,et al.  Schiff Bases: A Short Survey on an Evergreen Chemistry Tool , 2013, Molecules.

[21]  R. Popa,et al.  Sugar-borate esters--potential chemical agents in prostate cancer chemoprevention. , 2013, Anti-cancer agents in medicinal chemistry.

[22]  K. Sztanke,et al.  An insight into synthetic Schiff bases revealing antiproliferative activities in vitro. , 2013, Bioorganic & medicinal chemistry.

[23]  M. Smietana,et al.  Boron and nucleic acid chemistries: merging the best of both worlds. , 2013, Chemical Society reviews.

[24]  G. Kabalka,et al.  Boronated carbohydrate derivatives as potential boron neutron capture therapy reagents. , 2013, Future medicinal chemistry.

[25]  P. Ramachandran.  Focusing on boron in medicinal chemistry. , 2013, Future medicinal chemistry.

[26]  A. Verma,et al.  Boron chemicals in diagnosis and therapeutics. , 2013, Future medicinal chemistry.

[27]  P. de Souza,et al.  Folate conjugation to polymeric micelles via boronic acid ester to deliver platinum drugs to ovarian cancer cell lines. , 2013, Biomacromolecules.

[28]  L. Ciani,et al.  Boron as a platform for new drug design , 2012, Expert opinion on drug discovery.

[29]  V. Dembitsky,et al.  Boron containing compounds as protease inhibitors. , 2012, Chemical reviews.

[30]  Zhen Liu,et al.  Restricted access boronate affinity porous monolith as a protein A mimetic for the specific capture of immunoglobulin G , 2012 .

[31]  R. Raines,et al.  Boronate-Mediated Biologic Delivery , 2012, Journal of the American Chemical Society.

[32]  F. Gamo,et al.  Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles. , 2012, Bioorganic & medicinal chemistry letters.

[33]  B. Sumerlin,et al.  Biomedical applications of boronic acid polymers , 2011 .

[34]  J. Balzarini,et al.  Activity and safety of synthetic lectins based on benzoboroxole-functionalized polymers for inhibition of HIV entry. , 2011, Molecular pharmaceutics.

[35]  S. Benkovic,et al.  Boron-containing inhibitors of synthetases. , 2011, Chemical Society reviews.

[36]  P. Messersmith,et al.  Catechol Polymers for pH-Responsive, Targeted Drug Delivery to Cancer Cells , 2011, Journal of the American Chemical Society.

[37]  Rajiv Trivedi,et al.  Efficient synthesis, structural characterization and anti-microbial activity of chiral aryl boronate esters of 1,2-O-isopropylidene-α-D-xylofuranose. , 2011, Bioorganic & medicinal chemistry letters.

[38]  J. Boucher,et al.  Aminoboronic acids and esters: from synthetic challenges to the discovery of unique classes of enzyme inhibitors. , 2011, Chemical Society reviews.

[39]  David Benito-Alifonso,et al.  Carbohydrate chemistry in drug discovery. , 2011, Organic & biomolecular chemistry.

[40]  S. Westcott,et al.  Arylspiroboronate esters: from lithium batteries to wood preservatives to catalysis. , 2011, Chemical Society reviews.

[41]  V. Dembitsky,et al.  Natural and synthetic small boron-containing molecules as potential inhibitors of bacterial and fungal quorum sensing. , 2011, Chemical reviews.

[42]  L. Modolo,et al.  Schiff bases: A short review of their antimicrobial activities , 2011 .

[43]  C. Mcguigan,et al.  Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications , 2010 .

[44]  R. Popa,et al.  Boron-containing compounds as preventive and chemotherapeutic agents for cancer. , 2010, Anti-cancer agents in medicinal chemistry.

[45]  D. Hall,et al.  Multistep phase-switch synthesis by using liquid-liquid partitioning of boronic acids: productive tags with an expanded repertoire of compatible reactions. , 2010, Angewandte Chemie.

[46]  Jing‐Juan Xu,et al.  A Reusable Interface Constructed by 3‐Aminophenylboronic Acid‐Functionalized Multiwalled Carbon Nanotubes for Cell Capture, Release, and Cytosensing , 2010 .

[47]  Moritz M. Reichvilser,et al.  Boronic acid mono- and diesters of the aldopentoses. , 2010, Carbohydrate research.

[48]  Hamed I. Ali,et al.  Synthesis, antitumor activity and molecular docking study of novel sulfonamide-Schiff's bases, thiazolidinones, benzothiazinones and their C-nucleoside derivatives. , 2010, European journal of medicinal chemistry.

[49]  Jin Chen,et al.  Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[50]  Yi Xia,et al.  Therapeutic potential of boron-containing compounds. , 2009, Future medicinal chemistry.

[51]  M. Lourenço,et al.  Synthesis and antitubercular activity of novel Schiff bases derived from d-mannitol. , 2009, Carbohydrate research.

[52]  Beat Ernst,et al.  From carbohydrate leads to glycomimetic drugs , 2009, Nature Reviews Drug Discovery.

[53]  R. Santillán,et al.  3-Aminophenylboronic acid as building block for the construction of calix- and cage-shaped boron complexes , 2009 .

[54]  J. Berenson.  Hematology: Bortezomib in newly diagnosed multiple myeloma , 2009, Nature Reviews Clinical Oncology.

[55]  Stephan M Levonis,et al.  Boronolectin with divergent fluorescent response specific for free sialic acid. , 2009, Chemical communications.

[56]  Zareen Akhter,et al.  N-(3-Nitrobenzylidene)aniline , 2008, Acta crystallographica. Section E, Structure reports online.

[57]  D. Matteson.  α‐Amido boronic acids: A synthetic challenge and their properties as serine protease inhibitors , 2008 .

[58]  N. Petasis.  Expanding Roles for Organoboron Compounds – Versatile and Valuable Molecules for Synthetic, Biological and Medicinal Chemistry , 2007 .

[59]  Andrea F Armstrong,et al.  The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy. , 2007, Dalton transactions.

[60]  H. Ge,et al.  Synthesis and antimicrobial activities of Schiff bases derived from 5-chloro-salicylaldehyde. , 2007, European journal of medicinal chemistry.

[61]  P. Yogeeswari,et al.  Abacavir prodrugs: microwave-assisted synthesis and their evaluation of anti-HIV activities. , 2006, Bioorganic & medicinal chemistry letters.

[62]  C. Ratledge,et al.  Schiff base conjugates of p-aminosalicylic acid as antimycobacterial agents. , 2006, Bioorganic & medicinal chemistry letters.

[63]  S. Westcott,et al.  Palladium salicylaldimine complexes containing boronate esters , 2005 .

[64]  D. Steinberg,et al.  Synthesis and evaluation of oxazaborolidines for antibacterial activity against Streptococcus mutans. , 2004, Journal of medicinal chemistry.

[65]  F. Seela,et al.  With Boronic Acids , 2004 .

[66]  S. Westcott,et al.  Synthesis and antifungal and antibacterial bioactivity of cyclic diamines containing boronate esters , 2003 .

[67]  B. Wang,et al.  Boronic acid compounds as potential pharmaceutical agents , 2003, Medicinal research reviews.

[68]  C. Decicco,et al.  P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease. , 2002, Bioorganic & medicinal chemistry letters.

[69]  T. James,et al.  Saccharide-accelerated hydrolysis of boronic acid imines , 2002 .

[70]  B. Bassler,et al.  Structural identification of a bacterial quorum-sensing signal containing boron , 2002, Nature.

[71]  S. Westcott,et al.  Synthesis and reactivity of novel Schiff bases containing boronate esters , 2002 .

[72]  Chi‐Huey Wong,et al.  Carbohydrate-Based Antibiotics: A New Approach to Tackling the Problem of Resistance. , 2001, Angewandte Chemie.

[73]  S. Westcott,et al.  ChemInform Abstract: Synthesis and Antifungal Properties of Benzylamines Containing Boronate Esters. , 2001 .

[74]  Cosima Stubenrauch,et al.  Sugar surfactants — aggregation, interfacial, and adsorption phenomena , 2001 .

[75]  T. Kawahata,et al.  Boromycin, an anti-HIV antibiotic. , 1996, Bioscience, biotechnology, and biochemistry.

[76]  Bradley D. Smith,et al.  Modification of a Boronic Acid Cleft Produces a Sodium-Saccharide Cotransporter , 1995 .

[77]  S. Shinkai,et al.  Electrochemical detection of saccharides by the redox cycle of a chiral ferrocenylboronic acid derivative: a novel method for sugar sensing , 1995 .

[78]  B. Das,et al.  A concise and general entry into (R)-4-hydroxy-2-substituted cyclopent-2-enones from D-glucose: chiral intermediates for the synthesis of PGE2, (–)-pentenomycin I, and allethrin , 1990 .

[79]  D. Cremer,et al.  General definition of ring puckering coordinates , 1975 .

[80]  E. M. Linday.  PRACTICAL INTRODUCTION TO MICROBIOLOGY , 1962, The Ulster Medical Journal.

[81]  C. Bowman,et al.  Cyclic Benzeneboronate Esters , 1958 .

[82]  H. Kuivila,et al.  ARENEBORONATES FROM DIOLS AND POLYOLS1 , 1954 .